Last reviewed · How we verify
Ozone treatment
Ozone treatment is a Small molecule drug developed by Ekrem Bilal Karaayvaz. It is currently in Phase 1 development. Also known as: Ozone therapy.
-
Baseline phase 1 → approval rate
+9.6pp
Industry-wide phase 1 drugs reach approval ~9.6% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2033–2036 | — |
| EMA | EU | 2034–2037 | +0.7 yr |
| MHRA | GB | 2034–2037 | +0.7 yr |
| Health Canada | CA | 2034–2038 | +0.9 yr |
| TGA | AU | 2034–2038 | +1.2 yr |
| PMDA | JP | 2034–2038 | +1.5 yr |
| NMPA | CN | 2035–2039 | +2.3 yr |
| MFDS | KR | 2034–2038 | +1.4 yr |
| CDSCO | IN | 2034–2039 | +1.8 yr |
| ANVISA | BR | 2035–2039 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | Ozone treatment |
|---|---|
| Also known as | Ozone therapy |
| Sponsor | Ekrem Bilal Karaayvaz |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Ozone Therapy With Biomimetic Oral Care for Cancer-Related Oral Mucositis (NA)
- Comparison of ESWT and Ultrasound-Guided Ozone Injection in Lateral Epicondylitis (NA)
- Ozone Injection vs ESWT for Chronic Achilles Tendinopathy (NA)
- Effect of Topical Ozone on The Healing Diabetic Foot Ulcer (NA)
- Ozone Application in Periodontal Treatment (NA)
- Efficacy and Safety of Cold Atmospheric Plasma Combined With Endovascular Intervention in Patients With Diabetic Foot Ulcers and Lower Extremity Arterial Occlusion (NA)
- Ozone Therapy for the Treatment of Oral Mucositis in Patients Undergoing Radio and Chemotherapy in the Head and Neck Region
- Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2026 and 2029.
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ozone treatment CI brief — competitive landscape report
- Ozone treatment updates RSS · CI watch RSS
- Ekrem Bilal Karaayvaz portfolio CI
Frequently asked questions about Ozone treatment
What is Ozone treatment?
Who makes Ozone treatment?
Is Ozone treatment also known as anything else?
What development phase is Ozone treatment in?
Related
- Manufacturer: Ekrem Bilal Karaayvaz — full pipeline
- Also known as: Ozone therapy
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing